The Company did not record a provision for U.S. federal income taxes for the three and six months ended June 30, 2019 because it expects to generate a loss for the year ended December 31, 2019. For the three months ended in June 30, 2019, the Company recognized a net income tax expense of $

19,000

that represents foreign taxes. The net income benefit of

0.1

million for the six months ended June 30, 2019, and

$0.4 million for

each of

the three and six months ended June 30, 2018, related to foreign research and development tax credits. The Company’s net U.S. deferred tax assets continue to be offset by a full valuation allowance.